Advanced search
Publication Cover
Journal of Medical Economics Volume 17, 2014 - Issue 2
Submit an article Journal homepage
1,227
Views
11
CrossRef citations to date
0
Altmetric
Oncology: Original Articles

Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin’s lymphoma in England and Wales

Sarah DewildeSHE BrusselsBelgium
,
Beth WoodsOxford Outcomes OxfordUK
,
Jean-Gabriel CastaigneMundipharma International Limited CambridgeUKCorrespondence[email protected]
,
Christopher ParkerOxford Outcomes OxfordUK
&
William DunlopMundipharma International Limited CambridgeUK
Pages 111-124 | Accepted 02 Dec 2013, Published online: 13 Jan 2014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.